Ignelzi Troy A. 4
4 · Rapport Therapeutics, Inc. · Filed Jun 10, 2024
Insider Transaction Report
Form 4
Ignelzi Troy A.
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-06-06+81,366→ 81,366 totalExercise: $17.00Exp: 2034-06-05→ Common Stock (81,366 underlying)
Footnotes (1)
- [F1]25% of the shares underlying this option shall vest and become exercisable on June 6, 2025, with the remaining shares vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.